SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-093990
Filing Date
2020-08-12
Accepted
2020-08-12 17:17:11
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020475d1_10q.htm 10-Q 618944
2 EXHIBIT 31.1 tm2020475d1_ex31-1.htm EX-31.1 7757
3 EXHIBIT 31.2 tm2020475d1_ex31-2.htm EX-31.2 7706
4 EXHIBIT 32.1 tm2020475d1_ex32-1.htm EX-32.1 4606
5 EXHIBIT 32.2 tm2020475d1_ex32-2.htm EX-32.2 4245
  Complete submission text file 0001104659-20-093990.txt   5569207

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ontx-20200630.xml EX-101.INS 1483014
7 XBRL TAXONOMY EXTENSION SCHEMA ontx-20200630.xsd EX-101.SCH 49278
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ontx-20200630_cal.xml EX-101.CAL 36573
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ontx-20200630_def.xml EX-101.DEF 180859
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ontx-20200630_lab.xml EX-101.LAB 427792
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ontx-20200630_pre.xml EX-101.PRE 322431
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 201096229
SIC: 2834 Pharmaceutical Preparations